Clinical Trials Sponsored by Shari L Hand

Total 312 results

Shari L Hand
TopMD Skin Care, Inc.

Terminated

A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema

Eczema | Atopic Dermatitis | Hand Eczema

United States
Silvia M. Pinango L.
Merck Sharp & Dohme LLC

Completed

Early Short-term Antibiotic Therapy in Penetrating Abdominal Trauma, 3 vs 7 Days

SURGICAL SITE INFECTION
Joseph L. Kuti, PharmD
Merck Sharp & Dohme LLC

Completed

Imipenem/Cilastatin/Relebactam PK in ECMO

Sepsis

United States
Benjamin L. England and Associates, LLC

Completed

Usability Study for the Beactive Brace Instructions for Use

Lower Back Pain
L. Nicolas Gonzalez Castro, MD, PhD
Merck Sharp & Dohme LLC

Recruiting

Surgical Pembro +/- Olaparib w TMZ for rGBM

Glioblastoma | Recurrent Glioblastoma

United States
Susan L. Greenspan
Eli Lilly and Company; University of Pittsburgh

Completed

Fracture (FX) Improvement With Teriparatide: FiX-IT Study (FiX-IT)

Osteoporosis | Atypical Femoral Fracture

United States
Jenna L Leclerc MD, PhD

Withdrawn

Pilot Study of Ketamine Sedation for Aneurysmal Subarachnoid Hemorrhage (PENDULUM)

Subarachnoid Hemorrhage, Aneurysmal
Peter L Greenberg
The Leukemia and Lymphoma Society

Completed

Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1, 2/High Risk

Myelodysplastic Syndromes

United States
University of Oklahoma
Eli Lilly and Company; Mark L. Wolraich, M.D.

Completed

Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD (B4Z-MC-X017)

Attention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD) | Fetal Alcohol Syndrome

United States
Thomas L. Ortel
National Heart, Lung, and Blood Institute (NHLBI)

Completed

COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

Covid19

United States
Robert L. Murphy
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Completed

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir (EraMune02)

HIV Infection

United States
Brittany L Smalls
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

OASIS: Peer Support for T2DM in Appalachia (Peer Coaches) (OASIS)

Diabetes Mellitus, Type 2

United States
Brittany L Smalls
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Social Network Analysis to Identify Community Health Workers

Type2 Diabetes

United States
Oregon Health and Science University
Research to Prevent Blindness; Robert L. Bacon Medical Foundation

Completed

Effect of Nitrous Oxide (N2O) on Intraocular Pressure in Healthy Volunteers

Glaucoma | Sedation

United States
Brittany L Smalls
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Social Support Intervention for Older Adults With T2DM

Type 2 Diabetes

United States
Jeffrey L. Saver
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial (FAST-MAG)

Cerebrovascular Accident

United States
Russell L. Woods
Research to Prevent Blindness / Lions Club International Foundation

Not yet recruiting

Training Oculo-motor Control to Improve Vision When Using a Preferred Retinal Locus

Central Visual Impairment
Sharp HealthCare
Fisher and Paykel Healthcare

Completed

3D Imaging of Neonatal Faces

Nose Deformities, Acquired

United States
VA Office of Research and Development
Malcom Randall VA Medical Center; Richard L. Roudebush VA Medical Center

Completed

Implementing Evidence in the Detection and Treatment of Post Stroke Depression

Mental Health | Health Services | Neurology

United States
Barbara L. Fredrickson, PhD
National Center for Complementary and Integrative Health (NCCIH)

Completed

Meditation and Decision Making Study III (MDMS3)

Meditation

United States
Organon and Co
Merck Sharp & Dohme LLC

Terminated

Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)

Atherosclerosis | Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) (ENHANCE)

Atherosclerosis | Hypercholesterolemia | Hyperlipoproteinemia Type II
Organon and Co
Merck Sharp & Dohme LLC

Completed

Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)

Hypercholesterolemia | Hyperlipidemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)

Rhinitis, Allergic, Seasonal
Organon and Co
Merck Sharp & Dohme LLC

Completed

Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)

Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)

Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)

Atherosclerosis | Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)

Atherosclerosis | Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)

Hypercholesterolemia | Coronary Heart Disease | Hyperlipidemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)

Atherosclerosis | Hypercholesterolemia | Coronary Heart Disease
Organon and Co
Merck Sharp & Dohme LLC

Completed

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

Atherosclerosis | Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)

Atherosclerosis | Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)

Coronary Artery Disease | Atherosclerosis | Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)

Atherosclerosis | Hypercholesterolaemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)

Primary Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Terminated

Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)

Coronary Artery Disease | Atherosclerosis | Hypercholesterolemia
Organon and Co
Merck Sharp & Dohme LLC

Completed

Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)

Hypercholesterolemia
Sharp HealthCare
Food and Drug Administration (FDA)

Completed

Safety of Manganese Restriction in Neonatal Parenteral Nutrition

Infant, Newborn, Disease

United States
Cynthia L Gay, MD
National Institute of Allergy and Infectious Diseases (NIAID); Argos Therapeutics

Completed

A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004

HIV

United States
Eli Lilly and Company
Merck Sharp & Dohme LLC

Completed

A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Soft Tissue Sarcoma

United States, Belgium, Denmark, France
Brigham and Women's Hospital
Merck Sharp & Dohme LLC

Completed

Predicting the Response to Montelukast by Genetic Variation in Asthmatics

Asthma

United States
Brigham and Women's Hospital
Merck Sharp & Dohme LLC

Recruiting

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

Bladder Cancer

United States
Eli Lilly and Company
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

Breast Cancer | Non Small Cell Lung Cancer

United States, Spain, France, Belgium, Italy, Taiwan, Turkey
Eli Lilly and Company
Merck Sharp & Dohme LLC

Completed

A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC

Stage IV Non-Small Cell Lung Cancer

Spain, United States, France, Japan
Eli Lilly and Company
Merck Sharp & Dohme LLC

Withdrawn

A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer

Advanced Cancer

United States, Spain, France
Brigham and Women's Hospital
Merck Sharp & Dohme LLC

Completed

A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients

Hyperglycemia | Hypertension | Obesity

United States
Brigham and Women's Hospital
Merck Sharp & Dohme LLC

Terminated

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

HIV-1 Infection

United States
Eli Lilly and Company
Merck Sharp & Dohme LLC

Completed

A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Advanced Cancer

United States, Australia, United Kingdom
Eli Lilly and Company
Merck Sharp & Dohme LLC

Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

Carcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal Junction

Germany, United States, Spain, United Kingdom, France, Japan
Eli Lilly and Company
Merck Sharp & Dohme LLC

Completed

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)

Carcinoma, Non-small Cell Lung

United States, Spain

Clinical Trials Sponsored by Shari L Hand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations